Capital Research Global Investors Amedisys Inc Transaction History

Capital Research Global Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$96.79 - $131.14 $28.8 Million - $39 Million	-297,500 Reduced 54.38%	249,566 $24.2 Million
Q1 2022 May 16, 2022	BUY	$124.79 - $178.09 $5.17 Million - $7.38 Million	41,446 Added 8.2%	547,066 $94.3 Million
Q4 2021 Feb 14, 2022	BUY	$136.32 - $184.41 $13.5 Million - $18.2 Million	98,766 Added 24.28%	505,620 $81.9 Million
Q3 2021 Nov 15, 2021	BUY	$149.1 - $270.32 $58.1 Million - $105 Million	389,654 Added 2265.43%	406,854 $60.7 Million
Q2 2020 Aug 14, 2020	BUY	$169.77 - $213.81 $2.92 Million - $3.68 Million	17,200 New	17,200 $3.42 Million

297

28.5M

181K

1.04M

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.74B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.